In early March 2020, at the beginning of the COVID-19 pandemic in the United States, the JHM Office of Human Subjects Research began to strategize ways to review COVID-19 related research in a timely and systematic manner. To support the effort, a group of experts drawn from the existing JHM IRB membership were formulated to review COVID-19 related research.

JHM IRB 3 along with experts drawn from the other JHM committees who serve as alternates for JHM IRB 3 members meet regularly as the Emergency Response IRB.

The members have expertise in a number of areas including infectious diseases, pharmacy and therapeutics, research ethics and general internal medicine. The Emergency Response IRB is dedicated to the review of COVID-19 related new protocol applications, and change in research applications for currently approved research adding some aspect of COVID-19 related research.

The members of the Emergency Response IRB are:

• Richard Moore, MD
  Chairman
  Professor of Internal Medicine
   
• Mary Catherine Beach, M.D.,M.P.H.
  Ethicist
  Professor, Division of General Internal Medicine
   
• Roy Brower, M.D
  Professor, Pulmonary
   
• Reverend Charles Goods
  Unaffiliated/Non-Scientific Member
   
• Bhakti Hansoti, MBCHB, MPH, PHD
  Assistant Professor, Emergency Medicine
   
• Craig Hendrix, M.D.
  P & T Committee
  Professor, Clinical Pharmacology
   
• Joseph Carrese, M.D.
  Ethicist
  Professor, Medicine Division of General Internal Medicine
   
• Reverend Calvin Keene
  Unaffiliated Member/Non-Scientific Member
   
• Howard Lederman M.D., Ph.D.
  Professor, Pediatrics & Medicine
   
• Verena Jorgensen, M.D.
  Pediatric Endocrinology
   
• Jonathan Zenilman, M.D.
  Professor, Infectious Diseases

Last Updated 7/1/2021